|
Originally published In Press as doi:10.1194/jlr.R300010-JLR200 on September 1, 2003
Journal of Lipid Research, Vol. 44, 2019-2029, November 2003
Copyright © 2003 by American Society for Biochemistry and Molecular Biology
Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease
Neelima B. Chauhan1
Research and Development, Veterans Affairs Chicago Health Care SystemWest Side VA Medical Center, Chicago, IL 60612
Department of NeuroAnesthesiology, University of Illinois at Chicago, Chicago, IL 60612
1 To whom correspondence should be addressed. e-mail: nchauhan{at}uic.edu
Alzheimer's disease (AD) is characterized by the deposition of ß-amyloid (Aß) plaques derived from the amyloidogenic processing; of a transmembrane protein called ß-amyloid precursor protein (APP). In addition to the known genetic/sporadic factors that promote the formation of Aß, the composition and structural dynamics of the membrane are also thought to play a significant role in the amyloidogenic processing of APP that promotes seeding of Aß.
This minireview reinforces the roles played by membrane dynamics, membrane microdomains, and cholesterol homeostasis in relation to amyloidogenesis, and reviews current strategies of lowering cholesterol in treating AD.
Supplementary key words ß-amyloid precursor protein processing lipid raft caveolae glycophosphatidylinositol apolipoprotein E

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. Paul, H. H. D. Meyer, K. Leidl, S. Soumian, and C. Albrecht
A novel enzyme immunoassay specific for ABCA1 protein quantification in human tissues and cells
J. Lipid Res.,
October 1, 2008;
49(10):
2259 - 2267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Goodenowe, L. L. Cook, J. Liu, Y. Lu, D. A. Jayasinghe, P. W. K. Ahiahonu, D. Heath, Y. Yamazaki, J. Flax, K. F. Krenitsky, et al.
Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia
J. Lipid Res.,
November 1, 2007;
48(11):
2485 - 2498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-i. Okuhira, M. L. Fitzgerald, D. A. Sarracino, J. J. Manning, S. A. Bell, J. L. Goss, and M. W. Freeman
Purification of ATP-binding Cassette Transporter A1 and Associated Binding Proteins Reveals the Importance of {beta}1-Syntrophin in Cholesterol Efflux
J. Biol. Chem.,
November 25, 2005;
280(47):
39653 - 39664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mohr, M. Klempt, B. Rathkolb, M. H. de Angelis, E. Wolf, and B. Aigner
Hypercholesterolemia in ENU-induced mouse mutants
J. Lipid Res.,
November 1, 2004;
45(11):
2132 - 2137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Hansel, A. Rahman, M. House, R. Ashfaq, K. Berg, C. J. Yeo, and A. Maitra
Met Proto-Oncogene and Insulin-Like Growth Factor Binding Protein 3 Overexpression Correlates with Metastatic Ability in Well-Differentiated Pancreatic Endocrine Neoplasms
Clin. Cancer Res.,
September 15, 2004;
10(18):
6152 - 6158.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|